MobileODT / Apollo Pilot
Mobile ODT has created the Enhanced Visual Assessment (EVA) System, an integrated cervical cancer screening and patient tracking system that enables ongoing engagement with patients through a smartphone platform.
The primary objective of the pilot was to evaluate the effectiveness of the EVA System, in comparison to existing cervical cancer screening techniques at various Apollo Hospital centers, to ensure it meets quality standards of standard screening methods. A secondary goal was to conduct quality assurance through image review of all screeners by an expert colposcopist in the secure, online portal to better understand the skill level and uniformity of protocol followed by providers.
January 5, 2016 - November 2, 2017
The pilot was conducted in 7 centers, spanning 4 states in India, to reach both rural and urban populations across all income levels. Locations in which pilots were conducted include:
Apollo First Med, Chennai
Apollo Aragonda/Apollo Total Health
Apollo Tondiarpet Hospital, Chennai
Apollo Specialty Hospital Vanagaram, Chennai
Apollo Hyderabad (2 locations)
- 700+ patients were screened with the EVA system.
The EVA System led to a suspected increase in the number of precancerous or cancerous cases detected at the primary screening where conventional Pap smears indicated a normal screening.
Using the EVA System as a screening method, almost three times as many women identified as having positive dysplasia with EVA in comparison to Pap smear. With EVA, these patients could be diagnosed and treated (or counseled) at the first visit, whereas a Pap smear would have missed these cases.
- High satisfaction: The EVA System was scored either 4/5 or 5/5 on all measures of feasibility, usability, ease of training, patient satisfaction, and satisfaction with MobileODT support and engagement.
- When asked how using the EVA System influenced the way providers interact with patients, response included: easy to describe the abnormal images, it helped in explaining the risk, increased awareness, simplicity, and understanding of need for follow-up.
- Both clinical and administrative decision makers have a focus on data proven technology adoption. Before moving to purchase, even if regulatory approval and non-inferiority trials exist, statistically significant data from within India is a requirement before purchase of devices.
- In India, a physical office with support staff is critical. Many decision makers will not purchase devices without a physical presence in India, as customer support for technologies is a critical component of a purchase decision.